Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia

Abstract Early-onset schizophrenia (EOS) may have stronger familial aggregation and a more severe outcome than adult-onset schizophrenia (AOS). MicroRNA (miRNA) takes on dual roles as a genetic and epigenetic modulator, which may mediate the influence of genetic risk. Neurological soft signs (NSS) a...

Full description

Bibliographic Details
Main Authors: Bao-Yu Chen, Jin-Jia Lin, Ming-Kun Lu, Hung-Pin Tan, Fong-Lin Jang, Sheng-Hsiang Lin
Format: Article
Language:English
Published: Nature Portfolio 2021-07-01
Series:npj Schizophrenia
Online Access:https://doi.org/10.1038/s41537-021-00164-1
_version_ 1827614965730639872
author Bao-Yu Chen
Jin-Jia Lin
Ming-Kun Lu
Hung-Pin Tan
Fong-Lin Jang
Sheng-Hsiang Lin
author_facet Bao-Yu Chen
Jin-Jia Lin
Ming-Kun Lu
Hung-Pin Tan
Fong-Lin Jang
Sheng-Hsiang Lin
author_sort Bao-Yu Chen
collection DOAJ
description Abstract Early-onset schizophrenia (EOS) may have stronger familial aggregation and a more severe outcome than adult-onset schizophrenia (AOS). MicroRNA (miRNA) takes on dual roles as a genetic and epigenetic modulator, which may mediate the influence of genetic risk. Neurological soft signs (NSS) are neurological abnormalities that may be intermediate phenotypes or endophenotypes for schizophrenia. Our previous study found poorer performance on NSS tests from patients with EOS and their unaffected first-degree relatives. Thus, we aimed to identify a set of aberrant neurodevelopmental-related miRNAs that could serve as potential biomarkers for EOS or schizophrenia with NSS. This study included 215 schizophrenia patients (104 EOS and 111 AOS), 72 unaffected first-degree relatives, 31 patients with bipolar disorder, and 100 healthy controls. Differential expression analysis revealed that miR-137, miR-34b, and miR-34c were significantly up-regulated in patients with schizophrenia and their unaffected first-degree relatives compared to healthy controls. Receiver operating characteristic (ROC) analysis showed that the miR-137 expression signature could be used to discriminate between patients with EOS and healthy controls (AUC = 0.911). Additionally, miR-34b had the highest ability to discriminate between EOS and AOS (AUC = 0.810), which may indicate different aetiological pathways to disease onset. Moreover, miR-137 dysregulation was correlated with almost all NSS subscales (i.e., sensory integration, motor sequencing, etc.) and, when EOS patients with NSS, miR-137 expression discriminated these patients from healthy controls to a greater extent (AUC = 0.957). These findings support the potential for neurodevelopmental-related miRNAs to be used as indicators of vulnerability to EOS.
first_indexed 2024-03-09T09:02:27Z
format Article
id doaj.art-af5f35c8f9da41ce8df26dfab4c34c08
institution Directory Open Access Journal
issn 2334-265X
language English
last_indexed 2024-03-09T09:02:27Z
publishDate 2021-07-01
publisher Nature Portfolio
record_format Article
series npj Schizophrenia
spelling doaj.art-af5f35c8f9da41ce8df26dfab4c34c082023-12-02T11:14:24ZengNature Portfolionpj Schizophrenia2334-265X2021-07-01711910.1038/s41537-021-00164-1Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophreniaBao-Yu Chen0Jin-Jia Lin1Ming-Kun Lu2Hung-Pin Tan3Fong-Lin Jang4Sheng-Hsiang Lin5Institute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityDepartment of Psychiatry, Chi Mei Medical CenterDepartment of Health, Jianan Mental HospitalDepartment of Health, Jianan Mental HospitalDepartment of Psychiatry, Chi Mei Medical CenterInstitute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityAbstract Early-onset schizophrenia (EOS) may have stronger familial aggregation and a more severe outcome than adult-onset schizophrenia (AOS). MicroRNA (miRNA) takes on dual roles as a genetic and epigenetic modulator, which may mediate the influence of genetic risk. Neurological soft signs (NSS) are neurological abnormalities that may be intermediate phenotypes or endophenotypes for schizophrenia. Our previous study found poorer performance on NSS tests from patients with EOS and their unaffected first-degree relatives. Thus, we aimed to identify a set of aberrant neurodevelopmental-related miRNAs that could serve as potential biomarkers for EOS or schizophrenia with NSS. This study included 215 schizophrenia patients (104 EOS and 111 AOS), 72 unaffected first-degree relatives, 31 patients with bipolar disorder, and 100 healthy controls. Differential expression analysis revealed that miR-137, miR-34b, and miR-34c were significantly up-regulated in patients with schizophrenia and their unaffected first-degree relatives compared to healthy controls. Receiver operating characteristic (ROC) analysis showed that the miR-137 expression signature could be used to discriminate between patients with EOS and healthy controls (AUC = 0.911). Additionally, miR-34b had the highest ability to discriminate between EOS and AOS (AUC = 0.810), which may indicate different aetiological pathways to disease onset. Moreover, miR-137 dysregulation was correlated with almost all NSS subscales (i.e., sensory integration, motor sequencing, etc.) and, when EOS patients with NSS, miR-137 expression discriminated these patients from healthy controls to a greater extent (AUC = 0.957). These findings support the potential for neurodevelopmental-related miRNAs to be used as indicators of vulnerability to EOS.https://doi.org/10.1038/s41537-021-00164-1
spellingShingle Bao-Yu Chen
Jin-Jia Lin
Ming-Kun Lu
Hung-Pin Tan
Fong-Lin Jang
Sheng-Hsiang Lin
Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
npj Schizophrenia
title Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
title_full Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
title_fullStr Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
title_full_unstemmed Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
title_short Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
title_sort neurodevelopment regulators mir 137 and mir 34 family as biomarkers for early and adult onset schizophrenia
url https://doi.org/10.1038/s41537-021-00164-1
work_keys_str_mv AT baoyuchen neurodevelopmentregulatorsmir137andmir34familyasbiomarkersforearlyandadultonsetschizophrenia
AT jinjialin neurodevelopmentregulatorsmir137andmir34familyasbiomarkersforearlyandadultonsetschizophrenia
AT mingkunlu neurodevelopmentregulatorsmir137andmir34familyasbiomarkersforearlyandadultonsetschizophrenia
AT hungpintan neurodevelopmentregulatorsmir137andmir34familyasbiomarkersforearlyandadultonsetschizophrenia
AT fonglinjang neurodevelopmentregulatorsmir137andmir34familyasbiomarkersforearlyandadultonsetschizophrenia
AT shenghsianglin neurodevelopmentregulatorsmir137andmir34familyasbiomarkersforearlyandadultonsetschizophrenia